Drugs / A/H5N1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00908687 | May 2009 → Jan 2010 | influenza | Intercell USA, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/H5N1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00908687 ↗ |
| Modality | Vaccine | “inactivated Influenza A/H5N1 Vaccine” NCT00908687 ↗ |
| Route | Intramuscular | “A/H5N1 Vaccine 30 µg HA i.m. on Day 0” NCT00908687 ↗ |